Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic disease.
about
Upregulated TNF Expression 1 Year After Bariatric Surgery Reflects a Cachexia-Like State in Subcutaneous Adipose TissueRole of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population.Gingival Tissue Inflammation Promotes Increased Matrix Metalloproteinase-12 Production by CD200Rlow Monocyte-Derived Cells in Periodontitis.
P2860
Identification of matrix metalloproteinase-12 as a candidate molecule for prevention and treatment of cardiometabolic disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of matrix metal ...... nt of cardiometabolic disease.
@en
Identification of matrix metal ...... nt of cardiometabolic disease.
@nl
type
label
Identification of matrix metal ...... nt of cardiometabolic disease.
@en
Identification of matrix metal ...... nt of cardiometabolic disease.
@nl
prefLabel
Identification of matrix metal ...... nt of cardiometabolic disease.
@en
Identification of matrix metal ...... nt of cardiometabolic disease.
@nl
P2093
P2860
P50
P1433
P1476
Identification of matrix metal ...... ent of cardiometabolic disease
@en
P2093
G Staffler
P2860
P2888
P304
P356
10.2119/MOLMED.2016.00068
P407
P577
2016-06-30T00:00:00Z
P6179
1068965842